Richard Steinhart

Insider Reports History

Location
New Haven, CT
Signature
/s/ Richard Steinhart
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Richard Steinhart:

Stock Role Class Num Shares Value Price $ Report Date Ownership
BioXcel Therapeutics, Inc. Chief Financial Officer Common Stock 6.44K $9.21K $1.43 22 Jul 2025 Direct
BioXcel Therapeutics, Inc. Chief Financial Officer Restricted Stock Units 317 $136 $0.35 15 Sep 2025 Direct
BioXcel Therapeutics, Inc. Chief Financial Officer Stock Option (right to buy) 270K 07 Jan 2025 Direct
ATOSSA THERAPEUTICS, INC. Director Stock Option (right to buy) 125K 15 May 2025 Direct
Actinium Pharmaceuticals, Inc. Director Stock Option (Right to Buy) 0 31 Mar 2025 Direct

Insider Reports Filed by Richard Steinhart

Symbol Company Period Transactions Value $ Form Type Role Filing Time
BTAI BioXcel Therapeutics, Inc. 14 Sep 2025 4 $0 4 Chief Financial Officer 16 Sep 2025, 19:04
BTAI BioXcel Therapeutics, Inc. 01 Aug 2025 1 $0 4 Chief Financial Officer 05 Aug 2025, 20:02
BTAI BioXcel Therapeutics, Inc. 22 Jul 2025 3 $0 4 Chief Financial Officer 22 Jul 2025, 20:26
BTAI BioXcel Therapeutics, Inc. 14 Jun 2025 4 $0 4 Chief Financial Officer 16 Jun 2025, 19:03
ATOS ATOSSA THERAPEUTICS, INC. 15 May 2025 1 $0 4 Director 16 May 2025, 16:05
ATNM Actinium Pharmaceuticals, Inc. 31 Mar 2025 8 $0 4 Director 02 Apr 2025, 18:22
BTAI BioXcel Therapeutics, Inc. 14 Mar 2025 4 $0 4 Chief Financial Officer 17 Mar 2025, 18:38
BTAI BioXcel Therapeutics, Inc. 07 Jan 2025 1 $0 4 Chief Financial Officer 10 Jan 2025, 20:00
BTAI BioXcel Therapeutics, Inc. 14 Dec 2024 6 -$207 4 Chief Financial Officer 17 Dec 2024, 18:06
BTAI BioXcel Therapeutics, Inc. 17 Sep 2024 2 -$3.95K 4 Chief Financial Officer 03 Oct 2024, 21:54
BTAI BioXcel Therapeutics, Inc. 14 Sep 2024 5 -$246 4 Chief Financial Officer 17 Sep 2024, 19:21
BTAI BioXcel Therapeutics, Inc. 22 Jul 2024 2 $0 4 Chief Financial Officer 01 Apr 2025, 18:07
ATOS ATOSSA THERAPEUTICS, INC. 27 Jun 2024 1 $0 4 Director 01 Jul 2024, 16:00
BTAI BioXcel Therapeutics, Inc. 14 Jun 2024 5 -$470 4 Chief Financial Officer 18 Jun 2024, 21:26
BTAI BioXcel Therapeutics, Inc. 14 Mar 2024 5 -$2.82K 4 Chief Financial Officer 08 Apr 2024, 19:32
ATNM Actinium Pharmaceuticals, Inc. 28 Dec 2023 1 $0 4 Director 29 Dec 2023, 17:23
BTAI BioXcel Therapeutics, Inc. 14 Dec 2023 2 $0 4 Chief Financial Officer 18 Dec 2023, 16:52
BTAI BioXcel Therapeutics, Inc. 14 Sep 2023 2 $0 4 Chief Financial Officer 18 Sep 2023, 17:49
BTAI BioXcel Therapeutics, Inc. 14 Jun 2023 2 $0 4 Chief Financial Officer 16 Jun 2023, 18:42
BTAI BioXcel Therapeutics, Inc. 14 May 2023 3 -$136K 4 Chief Financial Officer 16 May 2023, 20:32
ATOS ATOSSA THERAPEUTICS, INC. 04 May 2023 1 $0 4 Director 05 May 2023, 19:35
BTAI BioXcel Therapeutics, Inc. 14 Mar 2023 5 -$40.6K 4 Chief Financial Officer 16 Mar 2023, 18:02
ATNM Actinium Pharmaceuticals, Inc. 01 Jul 2022 1 $0 4 Director 01 Jul 2022, 19:16
BTAI BioXcel Therapeutics, Inc. 14 May 2022 1 $0 4 Senior VP and CFO 17 May 2022, 15:40
ATOS ATOSSA THERAPEUTICS, INC. 13 May 2022 1 $0 4 Director 16 May 2022, 18:20
BTAI BioXcel Therapeutics, Inc. 14 Mar 2022 2 $0 4 Chief Financial Officer 16 Mar 2022, 16:16
ATNM Actinium Pharmaceuticals, Inc. 01 Sep 2021 1 $0 4 Director 03 Sep 2021, 17:02
ATOS ATOSSA THERAPEUTICS, INC. 14 May 2021 1 $0 4 Director 18 May 2021, 16:16